Asymmetric Functioning of Dimeric Metabotropic Glutamate Receptors Disclosed by Positive Allosteric Modulators*

The recent discovery of positive allosteric modulators (PAMs) for G-protein-coupled receptors open new possibilities to control a number of physiological and pathological processes. Understanding the mechanism of action of such compounds will provide new information on the activation process of these important receptors. Within the last 10 years, a number of studies indicate that G-protein-coupled receptors can form dimers, but the functional significance of this phenomenon remains elusive. Here we used the metabotropic glutamate receptors as a model, because these receptors, for which PAMs have been identified, are constitutive dimers. We used the quality control system of the GABAB receptor to generate metabotropic glutamate receptor dimers in which a single subunit binds a PAM. We show that one PAM/dimer is sufficient to enhance receptor activity. Such a potentiation can still be observed if the subunit unable to bind the PAM is also made unable to activate G-proteins. However, the PAM acts as a non-competitive antagonist when it binds in the subunit that cannot activate G-proteins. These data are consistent with a single heptahelical domain reaching the active state per dimer during receptor activation.

[1]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[2]  L. Bristow,et al.  Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. , 2003, Molecular pharmacology.

[3]  L. Prézeau,et al.  Closed state of both binding domains of homodimeric mGlu receptors is required for full activity , 2004, Nature Structural &Molecular Biology.

[4]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[5]  L. Prézeau,et al.  Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Kew,et al.  Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential. , 2004, Pharmacology & therapeutics.

[7]  L. Prézeau,et al.  Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function , 2001, The EMBO journal.

[8]  Eric Trinquet,et al.  Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. , 2004, Analytical biochemistry.

[9]  J. Kemp,et al.  Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Nakanishi,et al.  Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. , 2000, The Journal of biological chemistry.

[11]  L. Prézeau,et al.  Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR , 2005, The EMBO journal.

[12]  L. Prézeau,et al.  The Second Intracellular Loop of Metabotropic Glutamate Receptors Recognizes C Termini of G-protein α-Subunits* , 2003, Journal of Biological Chemistry.

[13]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[14]  Paul A Whittaker,et al.  The role of bioinformatics in target validation. , 2004, Drug discovery today. Technologies.

[15]  Xiaodong Li,et al.  Different functional roles of T1R subunits in the heteromeric taste receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[17]  Francine Acher,et al.  Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. A. Jensen,et al.  Allosteric modulation of G-protein coupled receptors. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  David Robbe,et al.  A simple method to transfer plasmid DNA into neuronal primary cultures: functional expression of the mGlu5 receptor in cerebellar granule cells , 1999, Neuropharmacology.

[20]  Jayaram Chandrashekar,et al.  An amino-acid taste receptor , 2002, Nature.

[21]  Yoshihiro Kubo,et al.  Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α , 2004, Nature Structural &Molecular Biology.

[22]  H. Hamm How activated receptors couple to G proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Prézeau,et al.  The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor* , 2004, Journal of Biological Chemistry.

[24]  P. Saintot,et al.  Locking the Dimeric GABAB G-Protein-Coupled Receptor in Its Active State , 2004, The Journal of Neuroscience.

[25]  P Jeffrey Conn,et al.  A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. , 2003, Molecular pharmacology.

[26]  N. Kunishima,et al.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Prézeau,et al.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[28]  A. Christopoulos,et al.  Allosteric modulators of G-protein-coupled receptors. , 2003, Current opinion in pharmacology.

[29]  Y. Jan,et al.  A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.

[30]  Krzysztof Palczewski,et al.  Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.

[31]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[32]  L. Prézeau,et al.  The activation mechanism of class-C G-protein coupled receptors , 2004 .

[33]  F. Ciruela,et al.  Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.

[34]  J. Olivo-Marin,et al.  The Metabotropic Glutamate Receptor mGluR5 Is Endocytosed by a Clathrin-independent Pathway* , 2003, The Journal of Biological Chemistry.

[35]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[36]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[37]  C. Romano,et al.  Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.

[38]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[39]  R. Duvoisin,et al.  Role of the Second and Third Intracellular Loops of Metabotropic Glutamate Receptors in Mediating Dual Signal Transduction Activation* , 1998, The Journal of Biological Chemistry.

[40]  Didier Rognan,et al.  Positive and Negative Allosteric Modulators of the Ca2+-sensing Receptor Interact within Overlapping but Not Identical Binding Sites in the Transmembrane Domain* , 2004, Journal of Biological Chemistry.

[41]  J. Bilezikian,et al.  The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[43]  J. Bockaert,et al.  Comparative effect of l-CCG-I, DCG-IV and γ-carboxy-l-glutamate on all cloned metabotropic glutamate receptor subtypes , 1998, Neuropharmacology.